Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Enzymatically active cathepsin D sensitizes breast carcinoma cells to TRAIL

B. Jancekova, E. Ondrouskova, L. Knopfova, J. Smarda, P. Benes,

. 2016 ; 37 (8) : 10685-96. [pub] 20160211

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17014099

Grantová podpora
NT13441 MZ0 CEP - Centrální evidence projektů

Cathepsin D (CD), a ubiquitously expressed lysosomal aspartic protease, is upregulated in human breast carcinoma and many other tumor types. CD has been repeatedly reported to act as key mediator of apoptosis induced by various chemotherapeutics. However, there is still controversy over the role of enzymatic/proteolytic versus protein-protein interaction activities of CD in apoptotic signaling. The elucidation of molecular mechanism responsible for the effect of CD in the chemotherapy-induced cell death is crucial for development of an appropriate strategy to target this protease in cancer treatment. Therefore, the objective of this study was to investigate the molecular mechanism behind the CD-mediated regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced cell death. For this purpose, MDA-MB-231 breast carcinoma cells with an increased level of wt CD (CD) or mutant enzymatically inactive CD (ΔCD) were subjected to TRAIL and the frequency of apoptosis was determined. Our results show that CD facilitates the TRAIL-induced apoptosis of MDA-MB-231 breast cancer cells in enzymatic activity-dependent manner. Moreover, the importance of endosomal/lysosomal acidification in this process was documented. Analysis of the potential substrates specifically cleaved by CD during the TRAIL-induced apoptosis confirmed caspase-8 and Bid proteins as the CD targets. Moreover, in search for protein regulators of apoptosis that can be cleaved by CD at physiologically relevant pH, we identified the Bcl-2 protein as a suitable candidate. The modulatory role of CD in cell response to TRAIL was also confirmed in another breast cancer cell line SKBR3. These experiments identified the CD enzymatic activity as a new factor affecting sensitivity of breast cancer cells to TRAIL.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17014099
003      
CZ-PrNML
005      
20181114101023.0
007      
ta
008      
170413s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s13277-016-4958-5 $2 doi
035    __
$a (PubMed)26867770
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Jančeková, Blanka $u Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic. International Clinical Research Center, Center for Biological and Cellular Engineering, St. Anne's, University Hospital Brno, Pekarska 53, 656 91, Brno, Czech Republic. $7 xx0282698
245    10
$a Enzymatically active cathepsin D sensitizes breast carcinoma cells to TRAIL / $c B. Jancekova, E. Ondrouskova, L. Knopfova, J. Smarda, P. Benes,
520    9_
$a Cathepsin D (CD), a ubiquitously expressed lysosomal aspartic protease, is upregulated in human breast carcinoma and many other tumor types. CD has been repeatedly reported to act as key mediator of apoptosis induced by various chemotherapeutics. However, there is still controversy over the role of enzymatic/proteolytic versus protein-protein interaction activities of CD in apoptotic signaling. The elucidation of molecular mechanism responsible for the effect of CD in the chemotherapy-induced cell death is crucial for development of an appropriate strategy to target this protease in cancer treatment. Therefore, the objective of this study was to investigate the molecular mechanism behind the CD-mediated regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced cell death. For this purpose, MDA-MB-231 breast carcinoma cells with an increased level of wt CD (CD) or mutant enzymatically inactive CD (ΔCD) were subjected to TRAIL and the frequency of apoptosis was determined. Our results show that CD facilitates the TRAIL-induced apoptosis of MDA-MB-231 breast cancer cells in enzymatic activity-dependent manner. Moreover, the importance of endosomal/lysosomal acidification in this process was documented. Analysis of the potential substrates specifically cleaved by CD during the TRAIL-induced apoptosis confirmed caspase-8 and Bid proteins as the CD targets. Moreover, in search for protein regulators of apoptosis that can be cleaved by CD at physiologically relevant pH, we identified the Bcl-2 protein as a suitable candidate. The modulatory role of CD in cell response to TRAIL was also confirmed in another breast cancer cell line SKBR3. These experiments identified the CD enzymatic activity as a new factor affecting sensitivity of breast cancer cells to TRAIL.
650    _2
$a adenokarcinom $x enzymologie $x patologie $7 D000230
650    _2
$a apoptóza $x účinky léků $7 D017209
650    _2
$a protein Bid $x metabolismus $7 D051023
650    _2
$a nádory prsu $x enzymologie $x patologie $7 D001943
650    _2
$a kaspasa 8 $x metabolismus $7 D053181
650    _2
$a kathepsin D $x antagonisté a inhibitory $x genetika $x fyziologie $7 D002402
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a chemorezistence $7 D019008
650    _2
$a endozomy $x metabolismus $7 D011992
650    _2
$a aktivace enzymů $7 D004789
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a koncentrace vodíkových iontů $7 D006863
650    _2
$a lyzozomy $x metabolismus $7 D008247
650    _2
$a nádorové proteiny $x antagonisté a inhibitory $x genetika $x fyziologie $7 D009363
650    _2
$a protoonkogenní proteiny c-bcl-2 $x metabolismus $7 D019253
650    _2
$a RNA interference $7 D034622
650    _2
$a malá interferující RNA $x genetika $7 D034741
650    _2
$a rekombinantní proteiny $x metabolismus $x farmakologie $7 D011994
650    _2
$a protein TRAIL $x farmakologie $7 D053221
650    _2
$a transfekce $7 D014162
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ondroušková, Eva $u Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic. Masaryk Memorial Cancer Institute, RECAMO, Zluty kopec 7, 656 53, Brno, Czech Republic. $7 _AN058804
700    1_
$a Knopfová, Lucia $u Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic. International Clinical Research Center, Center for Biological and Cellular Engineering, St. Anne's, University Hospital Brno, Pekarska 53, 656 91, Brno, Czech Republic. $7 xx0208986
700    1_
$a Šmarda, Jan, $u Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic. $d 1961- $7 mzk2006343362
700    1_
$a Beneš, Petr $u Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic. pbenes@sci.muni.cz. International Clinical Research Center, Center for Biological and Cellular Engineering, St. Anne's, University Hospital Brno, Pekarska 53, 656 91, Brno, Czech Republic. pbenes@sci.muni.cz. $7 xx0208982
773    0_
$w MED00008757 $t Tumour biology the journal of the International Society for Oncodevelopmental Biology and Medicine $x 1423-0380 $g Roč. 37, č. 8 (2016), s. 10685-96
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26867770 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20181114101109 $b ABA008
999    __
$a ok $b bmc $g 1200564 $s 974877
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 37 $c 8 $d 10685-96 $e 20160211 $i 1423-0380 $m Tumor biology $n Tumor Biol $x MED00008757
GRA    __
$a NT13441 $p MZ0
LZP    __
$a Pubmed-20170413

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...